Showing results (1331-1340 of 4,882) with videos related to

Sort By:
Pageof 489
Urologic Oncology|January 14, 2022
Surgical outcomes for older patients with renal cell carcinoma and inferior vena cava thrombusYudai Ishiyama, Tsunenori Kondo, Hidekazu Tachibana, et al.
Urologic Oncology|November 29, 2021
Targeted therapies: Expanding the role of FGFR3 inhibition in urothelial carcinomaZeynep B Zengin, Alex Chehrazi-Raffle, Nicholas J Salgia, et al.
Urologic Oncology|September 4, 2022
Evaluation of post-ablation mpMRI as a predictor of residual prostate cancer after focal high intensity focused ultrasound (HIFU) ablationYash S Khandwala, Shravan Morisetty, Pejman Ghanouni, et al.
Urologic Oncology|September 10, 2022
Mohs microsurgery for localized penile carcinoma: 10 year retrospective review of local recurrence rates and surgical complicationsNicolas E Alcalá, Katy L Reines, Bradley Merritt, et al.
Urologic Oncology|December 14, 2021
The bladder epicheck test and cytology in the follow-up of patients with non-muscle-invasive high grade bladder carcinomaFrancesco Pierconti, Maurizio Martini, Tonia Cenci, et al.
Urologic Oncology|December 13, 2021
Robotic-Assisted Video-Endoscopic Inguinal Lymphadenectomy (RAVEIL) and Video-Endoscopic Inguinal Lymphadenectomy (VEIL) versus Open Inguinal Lymph-Node Dissection (OILND) in carcinoma of penis: Comparison of perioperative outcomes, complications and oncological outcomes. A systematic review and meta-analysisKeval N Patel, Abhijeet Salunke, Ganesh Bakshi, et al.
Urologic Oncology|December 18, 2021
Extraperitonealization of ileal conduit reduces parastomal hernia after cystectomy and ileal conduit diversionZhiyong Li, Zhiling Zhang, Huali Ma, et al.
Urologic Oncology|November 24, 2021
Clinical and pathological features of renal epithelioid angiomyolipoma (PEComa): A single institution seriesRagheed Saoud, Tanya W Kristof, Clark Judge, et al.
Urologic Oncology|November 26, 2021
Validating the association of adverse pathology with distant metastasis and prostate cancer mortality 20-years after radical prostatectomyMichael A Brooks, Lewis Thomas, Cristina Magi-Galluzzi, et al.
Urologic Oncology|January 2, 2022
The management of toxicities from immune, targeted and ADCs treatments in patients with urothelial cancerSaad Atiq, Nathan Hirshman, Afreen Shariff, et al.
Pageof 489